Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Prognostic Factors in Cancer -

Prognostic Factors in Cancer

Paul Hermanek, etc. (Herausgeber)

Buch | Softcover
832 Seiten
2001 | 2nd Revised edition
John Wiley & Sons Inc (Verlag)
978-0-471-40633-4 (ISBN)
CHF 99,90 inkl. MwSt
  • Titel ist leider vergriffen;
    keine Neuauflage
  • Artikel merken
Divided into two parts, the first section of this book examines prognosis, specifically prognosis in cancer patients. The second section provides chapters on site-specific or tumor-specific neoplasms and the prognostic factors associated with them. These chapters include summaries that classify prognostic factors.
"Prognostic Factors in Cancer, Second Edition" updates the first authoritative monograph on prognostic factors and their use in planning treatment for cancer patients. The text is an extension of the work of the International Union Against Cancer (UICC) on the TNM Classification of Malignant Tumours and their current focus on prognostic factors in cancer. The TNM classification is the most widely used system for staging the progression of cancer. The anatomic extent of disease represented by the TNM system is the single most important predictor for outcomes of most tumors. "Prognostic Factors in Cancer, Second Edition" is divided into two parts. The first section examines prognosis in general and more specifically prognosis in cancer patients, including issues surrounding accuracy of measurement of prognosis, the methodology of studying and classifying prognostic factors, and the application of prognostic factors in clinical decision-making in the treatment of cancer. The second section provides chapters on site-specific or tumor-specific neoplasms and the prognostic factors associated with them.
These chapters contain an overview of the relevant literature and include summaries that classify prognostic factors according to subject and relevance. "Prognostic Factors in Cancer, Second Edition" illustrates the scope of the field as it stands today, and will provide perspective on likely outcomes of neoplastic disease for all physicians and others responsible for the care of patients with cancer.

Preface. Acknowledgments. Contributors. PRINCIPLES OF PROGNOSTIC FACTORS. The Importance Of Prognosis in Cancer Medicine (W. Mackillop). Prognostic Factors: Principles and Application (M. Gospodarowicz & B. O'Sullivan). Statistical Methods for the Analysis of Prognostic Factor Studies (L. McShane & R. Simon). Evaluating Prognostic Factor Studies (R. Simon). Artificial Neural Networks for Physicians: A Technology Introduction (D. Rodvold, et al.). Tumor, Host, and Environment--related Prognostic Factors (O'Sullivan, et al.). Prognostic Factors in Cancer Patient Care (M. Gospodarowicz & B. O'Sullivan). Psychosocial Factors in Prognosis (C. Edmonds & A. Cunningham). The Role of Prognostic Factors in Cancer Research (P. Groome & W. Mackillop). Measuring the Accuracy of Prognostic Judgments (W. Mackillop, et al.). PROGNOSTIC FACTORS IN SPECIFIC CANCERS. Section 1: Head And Neck Tumors. Oral Cavity, Pharynx, and Larynx Cancer (J.--L. Lefebvre, et al.). Paranasal Sinus Cancer (J. Waldron & I. Witterick). Nasopharyngeal Carcinoma (B. O'Sullivan & V. Chong). Salivary Gland Cancers (J. Califano & R. Spiro). Thyroid Cancer (J. Brierley & S. Asa). Second 2: Digestive System Tumors. Cancer of the Esophagus (H. Stein & M. Feith). Gastric Cancer (J. van Krieken, et al.). Colorectal Cancer (T. Hobday & C. Erlichman). Anal Cancer (B. Cummings). Hepatocellular Carcinoma (P. Johnson). Extrahepatic Biliary Tract and the Ampulla of Vater Cancers (D. Henson, et al.). Cancer of the Pancreas (J. Roder & K. Ott). Section 3: Lung and Plunal Tumors. Lung Cancer (M. Brundage & W. Mackillop). Malignant Pleural Mesothelioma (H.--N. Koong, et al.). Malignant Thymoma (D. Payne). Second 4: Tumors of Bone and Soft Tissues. Osteosarcoma (A. Davis, et al.). Soft Tissue Sarcoma (P. Pisters, et al.). Section 5: Skin Tumors. Skin Cancer (M. Poulsen). Cutaneous Malignant Melanoma (P. Heenan, et al.). Section 6: Breast Cancer. Breast Cancer (P. Fitzgibbons). Section 7: Gynecologic Cancers. Vulvar Cancer (J. Benedet & T. Ehlen). Uterine Cervix Cancer (G. Pitson & A. Fyles). Endometrial Cancer (J. Benedet & D. Miller). Cancer of the Ovary and Fallopian Tube (S. Pecorelli, et al.). Gestational Trophoblastic Disease (H. Ngan & L.--C. Wong). Section 8: Urological Tumors. Squamous--cell Carcinoma of the Penis (S. Horenblas). Prostate Cancer (L. Denis & G. Murphy). Germ--cell Testis Tumors (H.--J. Schmoll & C. Rie). Renal--cell Carcinoma (H. Poppel, et al.). Bladder Cancer (P. Bassi & F. Pagano). Section 9: Ophthalmic Tumors. Intraocular Tumors (A. Singh, et al.). Section 10: Hematologic Malignancies. Hodgkin's Disease (L. Specht). Non--Hodgkin's Malignant Lymphoma (M. Crump & M. Gospodarowicz). Leukemia (M. Minden). Section 11: Brain Tumors. Gliomas (H. Ohgaki, et al.). Section 12: Pediatric Tumors. Pediatric Cancers (K. Marcus & D. Hodgson). Epilogue. Glossary. Index.

Erscheint lt. Verlag 24.4.2001
Überarbeitung Mary K. Gospodarowicz, etc.
Zusatzinfo Ill.
Verlagsort New York
Sprache englisch
Maße 154 x 235 mm
Gewicht 1162 g
Einbandart Paperback
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Onkologie
ISBN-10 0-471-40633-3 / 0471406333
ISBN-13 978-0-471-40633-4 / 9780471406334
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Hannes Leischner

Buch | Softcover (2023)
Urban & Fischer in Elsevier (Verlag)
CHF 37,80
Resilienz innovativ stärken : ein Praxishandbuch

von Christa Diegelmann; Margarete Isermann; Tanja Zimmermann

Buch | Softcover (2023)
Kohlhammer (Verlag)
CHF 49,95